Kura Oncology
KURA
14 hedge funds and large institutions have $86.1M invested in Kura Oncology in 2015 Q4 according to their latest regulatory filings, with 14 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
47.95% more ownership
Funds ownership: 0% → 47.95% (+48%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$24.5M |
| 2 |
EcoR1 Capital
San Francisco,
California
|
+$19.3M |
| 3 |
PFM Health Sciences
San Francisco,
California
|
+$11.8M |
| 4 |
Clough Capital Partners
Boston,
Massachusetts
|
+$8.56M |
| 5 |
Franklin Resources
San Mateo,
California
|
+$7.64M |
Top Sellers
KURA Hedge Fund Activity: Q4 2015 in Review
14 of the 3,824 institutional investors tracked by Wall St. Rank reported a position in Kura Oncology (KURA) for Q4 2015, worth a combined $86.1M.
Buyers outnumbered sellers: 14 funds opened new KURA positions and 0 closed out — a net gain of 14 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Fidelity Investments, opening a new position worth an estimated $24.5M.
- 14 institutional investors held Kura Oncology (KURA) as of Q4 2015, up from 0 in Q3 2015.
- Funds reported $86.1M of Kura Oncology stock for Q4 2015.
- 14 funds opened new Kura Oncology positions in Q4 2015 and 0 closed out, a net change of +14 holders.
- The largest Kura Oncology buyer in Q4 2015 was Fidelity Investments, an estimated $24.5M added.
Based on aggregated 13F filings for Q4 2015.